Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Feb 28, 2026

Discover Swiss Pharmaceuticals & Biotech Growth Stocks that are on the SMI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
IDIA	CHF 3.92	6.0%	185.8%	CHF 984.6m	CHF 4.83	4.2	64.6%	n/a
PPGN	CHF 25.70	-3.9%	24.8%	CHF 847.9m	CHF 36.14	2.5	64.4%	0%
KURN	CHF 27.06	3.9%	22.4%	CHF 1.1b	CHF 34.65	10.3	60.9%	n/a
BSLN	CHF 55.20	2.6%	17.1%	CHF 678.5m	CHF 86.06	16.9	40.6%	n/a
SKAN	CHF 52.30	-3.1%	-28.3%	CHF 1.2b	CHF 70.33	72.7	32.2%	0.8%
COPN	CHF 113.80	-4.5%	73.2%	CHF 1.8b	CHF 116.75	33.3	31.4%	1.6%
NWRN	CHF 18.60	-3.4%	87.9%	CHF 372.3m	CHF 40.26	16.2	31.2%	n/a
GALD	CHF 145.90	-5.4%	32.7%	CHF 34.6b	CHF 165.24	119.2	26.9%	0.09%
DESN	CHF 360.00	3.4%	78.7%	CHF 5.0b	CHF 412.50	41.1	17.5%	0%
LONN	CHF 536.20	-0.04%	-5.7%	CHF 37.7b	CHF 676.22	41.4	17.3%	0.9%
BANB	CHF 59.40	-8.7%	2.5%	CHF 4.5b	CHF 78.66	33.2	17.0%	1.4%
SDZ	CHF 68.02	1.5%	72.0%	CHF 29.4b	CHF 61.50	41.9	16.8%	1.2%
TECN	CHF 136.20	-1.2%	-30.3%	CHF 1.7b	CHF 196.78	27.4	13.1%	2.2%
ROG	CHF 367.00	-0.2%	22.7%	CHF 293.5b	CHF 355.48	22.7	10.5%	2.7%
SFZN	CHF 85.70	4.4%	-10.8%	CHF 3.8b	CHF 108.70	22.3	9.9%	0.5%
NOVN	CHF 130.50	3.2%	33.6%	CHF 249.0b	CHF 115.28	23.2	8.5%	2.8%
MOLN	CHF 3.87	4.6%	-7.9%	CHF 144.7m	CHF 9.00	1.5	-2.8%	n/a
BIOV	CHF 24.40	3.4%	-31.0%	CHF 142.7m	CHF 56.38	109.0	-14.8%	n/a
SANN	CHF 16.90	5.6%	3.9%	CHF 235.4m	CHF 30.00	4.8	48.7%	n/a
XLS	CHF 22.50	6.1%	19.0%	CHF 129.8m	n/a	4.2	n/a	n/a
CURN	CHF 18.65	7.2%	63.6%	CHF 96.1m	CHF 98.10	n/a	n/a	n/a
MMTX	CHF 0.70	-26.2%	n/a	CHF 106.8m	CHF 3.56	n/a	n/a	n/a
ADXN	CHF 0.048	0%	-23.1%	CHF 5.6m	n/a	35.3	n/a	n/a

Page 1 of 1